27 related articles for article (PubMed ID: 21640545)
1. The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat Liver Resection.
Gon H; Komatsu S; Omiya S; Kido M; Fukushima K; Urade T; Yoshida T; Arai K; Ishida J; Nanno Y; Tsugawa D; Yanagimoto H; Toyama H; Fukumoto T
Anticancer Res; 2024 May; 44(5):2031-2038. PubMed ID: 38677757
[TBL] [Abstract][Full Text] [Related]
2. Proposal of an integrated staging system using albumin-bilirubin grade and serum alpha-fetoprotein values for predicting postoperative prognosis of recurrent hepatocellular carcinoma.
Matsumoto T; Shiraki T; Niki M; Sato S; Tanaka G; Shimizu T; Yamaguchi T; Park KH; Mori S; Iso Y; Ishizuka M; Kubota K; Aoki T
Eur J Surg Oncol; 2024 Jun; 50(6):108356. PubMed ID: 38685177
[TBL] [Abstract][Full Text] [Related]
3. Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC.
Matsuda M; Asakawa M; Amemiya H; Fujii H
J Gastroenterol Hepatol; 2011 Apr; 26(4):731-8. PubMed ID: 21155886
[TBL] [Abstract][Full Text] [Related]
4. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
5. Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma.
Eguchi S; Kanematsu T; Arii S; Omata M; Kudo M; Sakamoto M; Takayasu K; Makuuchi M; Matsuyama Y; Monden M;
Br J Surg; 2011 Apr; 98(4):552-7. PubMed ID: 21267990
[TBL] [Abstract][Full Text] [Related]
6. Appropriate liver resection type for patients with the American joint committee on cancer classification T1 and T2 hepatocellular carcinoma.
Hsieh CB; Chung KP; Chu CM; Yu JC; Hsieh HF; Chu HC; Yu CY; Chen TW
Eur J Surg Oncol; 2011 Jun; 37(6):497-504. PubMed ID: 21450438
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors and outcome in patients with intrahepatic recurrence after hepatectomy for hepatocellular carcinoma].
Yang LT; Cheng XD; Du YA; Wang XB; Zhang YL; Guo JM
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):612-6. PubMed ID: 20021950
[TBL] [Abstract][Full Text] [Related]
8. Prognostic effect of steatosis on hepatocellular carcinoma patients after liver resection.
Wu TH; Yu MC; Chan KM; Lee CF; Chen TC; Chang HC; Chou HS; Wu TJ; Eldeen FZ; Chen MF; Lee WC
Eur J Surg Oncol; 2011 Jul; 37(7):618-22. PubMed ID: 21640545
[TBL] [Abstract][Full Text] [Related]
9. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
[TBL] [Abstract][Full Text] [Related]
10. A review of prognostic scores after liver resection in hepatocellular carcinoma: the MSKCC, SLICER and SSCLIP scores.
Chan EE; Chow PK
Jpn J Clin Oncol; 2017 Apr; 47(4):287-293. PubMed ID: 27980082
[TBL] [Abstract][Full Text] [Related]
11. [Liver resections for primary liver malignancies. Personal results and analysis of the literature].
Zieren J; Zieren HU; Müller JM
Langenbecks Arch Chir; 1994; 379(3):159-67. PubMed ID: 8052057
[TBL] [Abstract][Full Text] [Related]
12. The malignant transformation of liver cell adenomas.
Foster JH; Berman MM
Arch Surg; 1994 Jul; 129(7):712-7. PubMed ID: 7517661
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
